Taken together, our findings identified that c-Abl-Drp1 signaling regulates mitochondrial morphology and neuronal cell death in response to oxidative stress, with implication of a new avenue for the treatment of oxidative stress-induced brain diseases by targeting c-Abl–Drp1 pathway. Here, DNM1L is linked to brain disorder.